Company: CMND
Filing Date: 2025-11-17
Form Type: 424B5
Source: 0001213900-25-111233
Chunk: 46

Company: Clearmind Medicine Inc.
Filing Date: 2025-11-17
Form: 424B5
Chunk 46
---
                                                                                        
 period over which we estimate our existing cash and cash equivalents will be sufficient to 
 fund our future operating expenses and capital expenditure requirements;                   |

| ● | our                                                                                            
 ability to generate revenue and profit margin under our anticipated contracts which is subject 
 to certain risks;                                                                              |

| ● | difficulties                                                                          
 in our and our partners’ ability to recruit and retain qualified physicians and other 
 healthcare professionals, and enforce our non-compete agreements with our physicians; |

| ● | our                                                                                           
 ability to restructure our operations to comply with future changes in government regulation; |

| ● | security,                                                                                     
 political and economic instability in the Middle East that could harm our business, including 
 due to the current war between Israel and Hamas; and                                          |

| ● | those                                                                                       
 factors referred to in our most recent annual report on Form 20-F incorporated by reference 
 herein in “Item 3. Key Information – D. Risk Factors,” “Item 4. Information                 
 on the Company,” and “Item 5. Operating and Financial Review and Prospects,”                
 as well as in our most recent annual report on Form 20-F generally, which is incorporated   
 by reference into this prospectus.                                                          |

Forward-looking statements are based on our management’s current expectations, estimates, forecasts and projections about our business and the industry in which we operate and our management’s beliefs and assumptions, and are not guarantees of future performance or development and involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control. As a result, any or all of our forward-looking statements in this prospectus may turn out to be inaccurate. Important factors that may cause actual results to differ materially from current expectations include, among other things, those listed under “Risk Factors” and elsewhere in this prospectus or any accompanying prospectus supplement. Potential investors are urged to consider these factors carefully in evaluating the forward-looking statements.

Further, any forward-looking statement speaks only as of the date on which it is made. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we assume no obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future. You should, however, review the factors and risks we describe in the reports we will file from time to time with the SEC after the date of this